Scientific article
OA Policy
English

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

Published inAnnals of the rheumatic diseases, vol. 66, no. 6, p. 754-763
Publication date2007
Abstract

Systemic sclerosis (SSc) is a multisystem autoimmune disease, which is classified into a diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subset according to the skin involvement. In order to better understand the vascular, immunological and fibrotic processes of SSc and to guide its treatment, the EULAR Scleroderma Trials And Research (EUSTAR) group was formed in June 2004.

Keywords
  • Adult
  • Age Distribution
  • Age of Onset
  • Aged
  • Autoantibodies/blood
  • Cross-Sectional Studies
  • Databases, Factual
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nuclear Proteins/immunology
  • Raynaud Disease/etiology/immunology
  • Risk Assessment
  • Scleroderma, Diffuse/complications/immunology
  • Scleroderma, Limited/complications/immunology
  • Scleroderma, Systemic/complications/immunology
  • Sex Factors
Citation (ISO format)
WALKER, U et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. In: Annals of the rheumatic diseases, 2007, vol. 66, n° 6, p. 754–763. doi: 10.1136/ard.2006.062901
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN0003-4967
548views
345downloads

Technical informations

Creation09/12/2014 11:55:00
First validation09/12/2014 11:55:00
Update time15/03/2023 00:25:14
Status update15/03/2023 00:25:13
Last indexation31/10/2024 01:42:28
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack